Proton Pump Inhibitors and ASA in the Treatment of Barrett's Esophagus Comment

被引:0
|
作者
Labenz, Joachim [1 ]
机构
[1] Diakonie Klinikum, Stuttgart, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1590 / +
页数:2
相关论文
共 50 条
  • [31] Do proton pump inhibitors induce regression of Barrett's esophagus? A systematic review.
    Howden, CW
    Hornung, CA
    GASTROENTEROLOGY, 1997, 112 (04) : A152 - A152
  • [32] The effect of oral administration of ursodeoxycholic acid and proton pump inhibitors in patients with Barrett's esophagus
    Bozikas, Andreas
    Marsman, Willem A.
    Rosmolen, Wilda D.
    van Baal, Jantine W.
    Kulik, Wim
    Ten Kate, Fiebo J.
    Krishnadath, Sheila K.
    Bergman, Jacques J.
    GASTROENTEROLOGY, 2006, 130 (04) : A565 - A566
  • [33] The effect of oral administration of ursodeoxycholic acid and proton pump inhibitors in patients with Barrett's esophagus
    Bergman, J. J.
    Bozikas, A.
    Marsman, W. A.
    Rosmolen, W. D.
    van Baal, J. W.
    Kulik, W.
    ten Kate, F. J.
    Krishnadath, K. K.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (10) : A54 - A55
  • [34] Regression of Barrett's Esophagus With Proton Pump Inhibitor Therapy
    Yada, T.
    Akiyama, J.
    Sakurai, T.
    Yokoi, C.
    Uemura, N.
    Triadafilopoulus, G.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2011, 45 (02) : 188 - 188
  • [35] Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea
    Jo, Hyun Jin
    Lee, Hye Seung
    Kim, Nayoung
    Nam, Ryoung Hee
    Chang, Hyun
    Kim, Min Soo
    Kim, Sung Eun
    Oh, Jane C.
    Lee, Dong Ho
    Jung, Hyun Chae
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2013, 19 (02) : 210 - 218
  • [36] Medications (NSAIDs, Statins, Proton Pump Inhibitors) and the Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus
    Nguyen, Dang M.
    Richardson, Peter
    El-Serag, Hashem B.
    GASTROENTEROLOGY, 2010, 138 (07) : 2260 - 2266
  • [37] DO PROTON PUMP INHIBITORS DECREASE THE RISK OF RESPIRATORY TRACT CANCERS IN PATIENTS WITH BARRETT'S ESOPHAGUS?
    Sanghi, Vedha
    Kumar, Mythri Anil
    Alkhayyat, Motasem
    Sanaka, Madhusudhan R.
    Butler, Robert
    Goldblum, John R.
    McMichael, John
    Thota, Prashanthi N.
    GASTROINTESTINAL ENDOSCOPY, 2020, 91 (06) : AB160 - AB160
  • [38] Barrett's esophagus: proton pump inhibitors and chemoprevention II (vol 1232, pg 114, 2011)
    Richter, Joel E.
    Penagini, Roberto
    Tenca, Andrea
    Pohl, Daniel
    Dvorak, Katerina
    Goldman, Aaron
    Savarino, Edoardo
    Zentilin, Patrizia
    Savarino, Vincenzo
    Watson, Joshua T.
    Wong, Roy K. H.
    Pace, Fabio
    Casini, Valentina
    Peura, David A.
    Herzig, Shoshana Joy
    Kamiya, Takeshi
    Pelosini, Iva
    Scarpignato, Carmelo
    Armstrong, David
    DeVault, Kenneth R.
    Bechi, Paolo
    Taddei, Antonio
    Freschi, Giancarlo
    Ringressi, Maria Novella
    Degli'Innocenti, Duccio Rossi
    Castiglione, Francesca
    Masini, Emmanuella
    Hunt, Richard H.
    CRITICAL CONTRIBUTIONS OF THE ORBITOFRONTAL CORTEX TO BEHAVIOR, 2011, 1239 : 162 - 162
  • [39] Use of proton pump inhibitors may cause squamous epithelial masking of intramucosal carcinoma in Barrett's esophagus
    Tanaka, K.
    Toyoda, H.
    Kadowaki, S.
    Hamada, Y.
    Kosaka, R.
    Yamanaka, M.
    Imoto, I.
    ENDOSCOPY, 2007, 39 : E105 - E106
  • [40] Barrett's oesophagus and proton pump inhibitors: a pathological perspective
    Shepherd, NA
    GUT, 2000, 46 (02) : 147 - 149